Semaglutide continued to exhibit a positive trend, with a coefficient of 27.3 (CI95%: [15.1, 39.6]).
← all excerpts
Impact of ADA Guidelines and Medication Shortage on GLP-1 Receptor Agonists Prescribing Trends in the UK: A Time-Series Analysis with Country-Specific Insights.
1
—
—